-
1.Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes 失效
标题翻译: 用作黑色素浓缩激素拮抗剂治疗肥胖和糖尿病的多环化合物公开(公告)号:US20050272718A1
公开(公告)日:2005-12-08
申请号:US10512986
申请日:2003-05-06
申请人: Jochen Ammenn , James Gillig , Lawrence Heinz , Philip Hipskind , Michael Kinnick , Yen-Shi Lai , John Morin , James Nixon , Carsten Ott , Kenneth Savin , Theo Schotten , Lawrence Slieker , Nancy Snyder , Michael Robertson
发明人: Jochen Ammenn , James Gillig , Lawrence Heinz , Philip Hipskind , Michael Kinnick , Yen-Shi Lai , John Morin , James Nixon , Carsten Ott , Kenneth Savin , Theo Schotten , Lawrence Slieker , Nancy Snyder , Michael Robertson
IPC分类号: A61K31/341 , A61K31/381 , A61K31/40 , A61K31/4196 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/4245 , A61K31/426 , A61K31/428 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61P1/00 , A61P1/04 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/06 , A61P9/04 , A61P9/10 , A61P9/12 , A61P11/06 , A61P11/14 , A61P13/02 , A61P13/08 , A61P15/12 , A61P19/02 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P27/02 , A61P29/00 , A61P43/00 , C07D207/333 , C07D249/08 , C07D261/08 , C07D263/32 , C07D271/06 , C07D271/10 , C07D271/107 , C07D277/26 , C07D285/12 , C07D307/42 , C07D333/18 , C07D413/02 , C07D413/04 , C07D413/06 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/12
CPC分类号: C07D249/08 , C07D261/08 , C07D263/32 , C07D271/06 , C07D271/10 , C07D271/107 , C07D277/26 , C07D333/18 , C07D413/04 , C07D413/06 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
摘要翻译: 本发明涉及式I的黑色素浓缩激素拮抗剂化合物:(I); 或其药学上可接受的盐,溶剂化物,对映异构体或前药,用于治疗,预防或改善与肥胖症和相关疾病相关的症状。
-
2.N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR 审中-公开
标题翻译: 作为5-HT6受体拮抗剂的N-(2-亚甲基)苄基苯胺公开(公告)号:US20070099909A1
公开(公告)日:2007-05-03
申请号:US11608922
申请日:2006-12-11
申请人: Zhaogen Chen , Michael Cohen , Matthew Fisher , Bruno Giethlen , James Gillig , Jefferson McCowan , Shawn Miller , John Schaus
发明人: Zhaogen Chen , Michael Cohen , Matthew Fisher , Bruno Giethlen , James Gillig , Jefferson McCowan , Shawn Miller , John Schaus
IPC分类号: A61K31/54 , A61K31/5375 , A61K31/405 , A61K31/495 , A61K31/426 , A61K31/421 , A61K31/4172 , A61K31/445 , A61K31/137
CPC分类号: C07D213/64 , C07C211/52 , C07C211/56 , C07C217/58 , C07C217/60 , C07C225/16 , C07C311/37 , C07C317/34 , C07C323/32 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/86 , C07D213/38 , C07D213/65 , C07D213/68 , C07D213/74 , C07D233/24 , C07D239/34 , C07D277/34 , C07D307/91 , C07D333/20 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D417/12 , C07D471/04 , C07F7/0812
摘要: The present invention provides compounds of formula (I), which are antagonists of the 5-HT6 receptor.
摘要翻译: 本发明提供作为5-HT 6受体的拮抗剂的式(I)化合物。
-
公开(公告)号:US20060052449A1
公开(公告)日:2006-03-09
申请号:US10536053
申请日:2003-12-03
申请人: James Gillig , Lawrence Heinz , Michael Kinnick , Yen-Shi Lai , John Morin , Nancy Snyder
发明人: James Gillig , Lawrence Heinz , Michael Kinnick , Yen-Shi Lai , John Morin , Nancy Snyder
IPC分类号: A61K31/205 , C07C323/39
CPC分类号: C07C323/60
摘要: The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar1, Ar2, Ar3, L1, L2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.
摘要翻译: 本发明涉及式I的黑色素浓缩激素拮抗剂化合物:(I)其中Ar 1,Ar 2,Ar 3,L 限定的1个或2个Q区域,或其可用于治疗,预防或改善与肥胖有关的症状的非对映异构体的药学上可接受的盐,溶剂合物,对映异构体或混合物 和相关疾病
-
4.BENZENESULFONIC ACID INDOL-5-YL ESTERS AS ANTAGONISTS OF THE 5-HT6 RECEPTOR 审中-公开
标题翻译: 作为5-HT6受体拮抗剂的苯并噻唑酸吲哚-5-酯公开(公告)号:US20070135484A1
公开(公告)日:2007-06-14
申请号:US11624389
申请日:2007-01-18
申请人: Sandra Filla , Michael Flaugh , James Gillig , Lawrence Heinz , Joseph Krushinski , Bin Liu , Marta Pineiro-Nunez , John Schaus , John Ward
发明人: Sandra Filla , Michael Flaugh , James Gillig , Lawrence Heinz , Joseph Krushinski , Bin Liu , Marta Pineiro-Nunez , John Schaus , John Ward
IPC分类号: A61K31/454 , C07D403/04
CPC分类号: C07D401/04 , C07D401/14 , C07D487/04
摘要: The present invention relates to compounds of formula I: which are antagonists of 5-HT6 receptor.
摘要翻译: 本发明涉及式I化合物,它是5-HT 6受体的拮抗剂。
-
公开(公告)号:US20070135485A1
公开(公告)日:2007-06-14
申请号:US10575815
申请日:2004-10-21
IPC分类号: A61K31/454 , A61K31/4245 , C07D413/02
CPC分类号: C07D271/10 , C07D413/04
摘要: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: or a pharmaceutically acceptable salt thereof, useful for the treamtment useful fog treating Type H diabetes and/or obesity.
摘要翻译: 本发明涉及式I的黑色素浓缩激素拮抗剂化合物或其药学上可接受的盐,其可用于治疗H型糖尿病和/或肥胖症的有效雾化。
-
6.N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor 有权
标题翻译: N-(2-芳基乙基)苄胺作为5-ht6受体的拮抗剂公开(公告)号:US20060009511A9
公开(公告)日:2006-01-12
申请号:US10472741
申请日:2002-03-15
申请人: Zhaogen Chen , Michael Cohen , Matthew Fisher , Bruno Giethlen , James Gillig , Jefferson McCowan , Shawn Miller , John Schaus
发明人: Zhaogen Chen , Michael Cohen , Matthew Fisher , Bruno Giethlen , James Gillig , Jefferson McCowan , Shawn Miller , John Schaus
IPC分类号: C07D209/04 , A61K31/404
CPC分类号: C07D213/64 , C07C211/52 , C07C211/56 , C07C217/58 , C07C217/60 , C07C225/16 , C07C311/37 , C07C317/34 , C07C323/32 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/86 , C07D213/38 , C07D213/65 , C07D213/68 , C07D213/74 , C07D233/24 , C07D239/34 , C07D277/34 , C07D307/91 , C07D333/20 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D417/12 , C07D471/04 , C07F7/0812
摘要: The present invention provides compounds of formula (I), which are antagonists of the 5-HT6 receptor.
摘要翻译: 本发明提供作为5-HT 6受体的拮抗剂的式(I)化合物。
-
-
-
-
-